Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 13 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its injectables manufacturing facility at Zydus Biotech Park in Ahmedabad. The inspection, which took place in June, concluded with no observations, indicating compliance with current good manufacturing practices. This announcement serves as a disclosure in accordance with regulatory requirements for the exchange and investors.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 13, 2023, titled "Zydus receives EIR for the injectables manufacturing facility at Zydus Biotech Park, Ahmedabad".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases